Evidence map›Paper›PMID 16838119›Full record

ReviewDigestive diseases and sciences2006

Effects of Saccharomyces boulardii on intestinal mucosa.

Jean-Paul Buts, Nadine De Keyser

Abstract readReview
PubMed Publisher
In one paragraph

Review in Digestive diseases and sciences, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. mSystems · 2023
    Article
  3. Article
  4. Article
  5. Frontiers in medicine · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Overview of the Potential Role ofFrontiers in cellular and infection microbiology · 2020
    Review
  10. Sepsis: mechanisms of bacterial injury to the patient.Scandinavian journal of trauma, resuscitation and emergency medicine · 2019
    Review
  11. Review
  12. Beneficial effects ofClinical and experimental gastroenterology · 2019
    Review
  13. Article
  14. Clinical medicine insights. Gastroenterology · 2018
    Review
  15. Article
  16. Protective Yeasts ControlFrontiers in cellular and infection microbiology · 2016
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jean-Paul ButsLaboratory of Pediatric Gastroenterology and Nutrition, Unit of Pediatric Research, Université Catholique de Louvain, Louvain, Belgium. buts@gype.ucl.ac.be
Nadine De Keyser
UCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saccharomyces boulardii (S. boulardii) is a non-pathogenic biotherapeutic agent, widely prescribed in a lyophilized form in many countries over the world. S. boulardii acts as a shuttle liberating effective enzymes, proteins and trophic factors during its intestinal transit that improve host immune defenses, digestion, and absorption of nutrients. In addition, S. boulardii secretes during its intestinal transit polyamines, mainly spermine and spermidine that regulate gene expression and protein synthesis. In this review, we will focus on the interactions of the yeast with the host intestinal mucosa.

Indexed as

SaccharomycesAnimalsHumansIntestinal DiseasesIntestinal MucosaIntestine, SmallMicroscopy, ElectronMicrovilliPolyaminesProbioticsPolyamines

Identifiers

PMID16838119
OpenAlexW2086760913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.